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ABSTRACT 
Over 7,000 Southeast Asian refugees live in the 
Salt Lake area. The hepatitis B carrier rate among 
Southeast Asians in the United States is 12-14%. A 
retrospective study was conducted to obtain data con-
cerning the prevalence of hepatitis B virus among 
Southeast Asian prenatal clients. The study sample 
consisted of 129 charts reviewed from two Salt Lake 
area clinics. The time period included all the South-
east Asian women receiving prenatal care who delivered 
in 1984 and those delivered or undelivered who had 
prenatal blood drawn prior to February 28, 1985. 
Demographic data revealed the sample to be 
between the ages of 15 and 44 years. Ninety-six 
percent were married and 60% were Cambodian. 
Of the 129 charts reviewed, 75 (58%) were 
screened for hepatitis B surface antigen (HBsAg). 
There was no significant difference by clinic in the 
percentage of subjects tested. 
Among the 75 subjects screened for HBsAg, 7 were 
HBsAg positive. The prevalance of HBsAg among South-
east Asians screened in this study was 9.3%. 
Inconsistent management of the HBsAg positive subjects 
and their infants has been noted. 
The findings of this study suggest that an inade-
quate number of Southeast Asians are being screened for 
hepatitis, and that further research in this area is 
warranted. 
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CHAPTER I 
INTRODUCTION AND REVIEW OF LITERATURE 
Since the fall of the Republic of South Vietnam in 
1975, over 600,000 Southeast Asian refugees have emi-
grated to the United States. Recent figures from the 
Utah Vital Statistics Department indicate that over 
7,000 refugees are in Utah. Approximately 90% of the 
refugees are under 40 years of age and 40% are female. 
Of the female population, approximately 80% are of 
childbearing age (Barry, Craft, Coleman, Coulter & 
Horwitz, 1983: Larsen, 1982). They are comprised of 
several subgroups: Vietnamese, ethnic Chinese/-
Vietnamese, Laotian, Hmongs, Cambodians or Khmers, 
ethnic Chinese/Cambodians, Black Thais, and Nungs, 
including variations within some of these groups (Cata-
zaro & Mozer, 1982: Center for Disease Control [CDC] 
1975, 1984). While acknowledging the fact that each 
group is distinguished by unique cultural and health 
practices, because specific cultural information is 
often not available on prenatal charts, the term 
Southeast Asian (SEA) is used to encompass all 
subgroups. 
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Th~ health problems of the Southeast Asians in-
clude tuberculosis, parasitism, hepatitis A and Band 
malaria. These diseases have been well documented and 
reflect illnesses indigenous to Southeast Asia (CDC, 
1979la, 1979b, 1979c, 1979d, 197ge, 1979f). Larsen, 
the Refugee Health Coordinator for the Utah State 
Health and Pulmonary Programs, has accumulated the 
following morbidity percentages for the Utah refugees: 
53% have positive tuberculin skin tests; 56% have at 
least one or more parasites; 75% need dental care; and 
12-21% are hepatitis B carriers. These figures are 
representative of Salt Lake City because over 75-80% of 
the total Utah refugees settled in the Salt Lake area 
(Larsen, 1982). Of all the health problems encountered 
in this population, hepatitis B and tuberculosis create 
the greatest public health concern. 
Southeast Asian refugees are routinely screened 
for tuberculosis and receive appropriate care and fol-
low up from public health agencies. Unfortunately, 
screening for hepatitis B is not routine, and the 
disease is often missed. Hepatitis B is infectious in 
both the acute and the carrier state. Carriers are 
usually healthy and show no signs of illness to warrant 
testing. A mother who is an infectious carrier has 
nearly a 100% chance of infecting her newborn. The 
Hepatitis B carrier who acquires the disease peri-
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natally is at risk for cirrhosis of the liver and 
primary hepatocellular carcinoma, both of which may be 
fatal. In addition to the newborn, health care pro-
viders are at particular risk. 
History of Hepatitis 
Acute viral hepatitis is a systemic infection 
primarily affecting the liver. Diseases of the liver, 
particularly jaundice, are described and found in the 
Babylonian Talmud, 5th century B.C. (McCallum & 
Bradley, 1944; Zukerman, 1975). Hippocrates described 
epidemic jaundice, the disease that is recognized today 
as hepatitis as "infectious icterus" (Krugman, 1978), 
and as the "fourth kind of jaundice" (Zukerman, 1975). 
Frequent occurrences of the disease were reported dur-
ing the seventeenth and eighteenth centuries among 
diverse populations and geographical areas. It was 
suspected that poor sanitation and large populations 
resulted in fecal contamination of food and water, 
which lead to viral hepatitis. 
The first identified (retrospectively) outbreak of 
hepatitis B was reported by Lurman in 1885. He des-
cribed "an epidemic of icterus" among shipyard workers 
who had been inoculated with smallpox vaccine made up 
of human serum (Lurman, 1885). It is probable that the 
donor was a carrier of hepatitis B virus. During the 
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first half of this century, additional outbreaks of 
"long incubation period hepatitis" occurred in various 
countries of the world. Many fatalities and illnesses 
during that time were unrecognized iatrogenic cases of 
serum hepatitis B virus (HBV). The outbreaks were 
caused by the use of hepatitis B contaminated needles, 
syringes, blood, and blood products (Findlay & 
MacCallum, 1937: Sawyer, Meyer, Eaton, Bauer, Putman & 
Schwentker, 1944; Krugman, 1978). 
Hepatitis B research was complicated by the in-
ability to find susceptible experimental animals. Hu-
man volunteer trials in the 1940s provided the only 
reliable method to study the disease (Krugman, 1978). 
The studies by Voegt (1942), McCallum and Bradley 
(1944), Havens, Ward, Drill and Paul (1944) and Paul, 
Havens, Sabin and Phillip (1945) demonstrated that 
hepati tis was caused by at least two viruses, subse-
quently named hepatitis A virus (HAV) and hepatitis B 
virus (HBV). The viruses were not actually seen but 
distinct epidemiological and immunological differences 
were noticed (Zukerman, 1975). Two important differ-
ences observed were the route of infection and the 
incubation period. The terms hepatitis A for infec-
tious or epidemic hepatitis, and hepatitis B for serum 
hepatitis or homologous serum jaundice were introduced 
by McCallum in 1947. These terms were generally adopt-
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ed in 1973 by the Scientific Group on Viral Hepatitis 
of the World Health Organization and by the Expert 
Committee on Viral Hepatitis in 1977 (Zukerman, 1975). 
Hepatitis B Virus 
Hepatitis B is caused by the hepatitis B virus 
(HBV), referred to as the Danes particle (Dienstag, 
Wands & Koff, 1983), and is usually found only in the 
liver cells (Cohen & Cohen, 1983). Replication of the 
virus occurs in the hepatocytes (Cohen & Cohen, 1983 ; 
Hoofnag1e, 1981). Although HBV is usually confined to 
the liver, in some cases it can be found in serum 
(Dienhardt, 1980). The HBV can be identified directly 
by electron microscopy or indirectly through immuno-
logical assays of its various antigens and antibodies. 
Since electron microscopy is expensive and tedious, the 
immunological assay is the method of choice (Cohen & 
Cohen, 1983). 
The virus is composed of an outer protein surface 
coat and a central core (Cohen & Cohen, 1983: Deinstag 
et a1., 1983). The core contains the DNA genome, 
hepatitis B core antigen (HBcAg), and proteins neces-
sary for its replication (Cohen & Cohen, 1983: Deinstag 
et a1., 1983: Hoofnag1e, 1981). Several of the viral 
proteins are antigenic, stimulating the immune system 
to form antibodies (Hoofnag1e, 1981). There are three 
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antigen-antibody systems associated with hepatitis B 
virus (HBV) : hepatitis B surface antigen (HbsAg) and 
its antibody (anti-HBs); hepati ti s B core antigen 
(HBcAg) and its antibody (anti-HBc); and hepatitis B 
"e" antigen (HbeAg) and its antibody (anti-HBe). When 
an individual is infected with HBV, the rise and fall 
of these antigens and their corresponding antibodies 
are evaluated serologically to assess the disease pro-
cess. 
HBsAg, formerly called the "Australia antigen," 
can be identified in serum 30-60 days after exposure to 
HBV and persists for variable periods (Hoofnagle, 1981; 
CDC, 1981b). This surface coat protein is produced in 
extraordinary quantities as noninfectious material 
during HBV replication (Lutwick, 1984). The measure-
ment of HBsAg determines the presence of HBV. It is 
believed that the liver parenchymal cell is the sole 
site of virus production (Lutwick, 1984), although the 
pancreas has also been implicated as another site for 
viral replication (Shimoda, Shikata & Karasawa, 1981). 
HBsAg level will usually decline prior to the 
cessation of clinical symptoms or during early conva-
lescence (CDC, 1981a; Coh~n & Cohen, 1983); although 
some individuals will remain HBsAg (positive) for life, 
resulting in a chronic HBV carrier state (CDC, 1981a). 
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The absence of HBsAg does not guarantee the absence of 
disease. There is often a gap or "window phase" be-
tween the clearance HBsAg and the appearance of anti-
bodies to HBs (CDC, 1981a; Deinstag et al., 1983; 
Hoofnagle, 1981). The hepatitis B He" antigen (HBeAg) 
correlates with the degree of infectivity of the serum. 
HBeAg appears early in the acute phase and usually 
disappears before HBsAg is gone (Cohen & Cohen, 1983; 
CDC, 1981b; Dienhardt, 1980). It indicates that the 
individual is highly infectious and is often seen early 
in the course of the illness (Cohen & Cohen, 1983). 
Anti-HBc is the most reliable serologic marker of 
hepatitis B virus infection (Hoofnagle, 1981). It is 
present in the serum at the onset of clinical symptoms 
(CDC, 1981a; Deinhardt, 1980) and remains high as long 
as HBV viral replication continues (CDC, 1981a; Hoof-
nagle, 1981). HBsAg is the serologic marker most fre-
quently used as it is the least expensive, and 
identifies those who are in the acute phase or who are 
long-term carriers. 
When screening Southeast Asians, HBsAg is usually 
sufficient since most Southeast Asians are long-term 
carriers. In cases where the HBsAg is positive, the 
blood should be tested for other HBV antigens and 
antibodies to determine the infectiousness and the 
stage of the illness. If there is a questionable 
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history of hepatitis or hepatitis symptoms or the pos-
sibility of a "window phase" anti-HBc should be evalu-
ated (Hoofnagle, 1981). 
The CDC recommends that women with the following 
risk factors should have prenatal serologic screening 
( CDC, 19 81 a ) : 
1. Asian descent or birth in an endemic area. 
2. Acute or chronic liver disease. 
3. Rejection as a blood donor. 
4. Work or treatment in a dialysis unit. 
5. Working or living in an institution for the 
retarded. 
6. Percutaneous drug abuse. 
7. Household members with hepatitis B. 
8. Prostitution. 
9. Occupational exposure to blood. 
Transmission of Hepatitis ~ Virus 
The transmission of hepatitis B virus has long 
been studied. The original designation of "serum hepa-
titis" is no longer an adequate label due to the varied 
modes of transmission recognized today. It is true 
that the major route of infection remains percutaneous 
(exposure to blood products through needle punctures 
and transfusions), but many indirect routes are also 
recognized. Due to minute breaks in tissue and mixing 
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of blood, HBsAg has been recovered in a variety of body 
fluids saliva, tears, seminal fluid, cerebrospinal 
fluid, breast milk, etc. (CDC, 1981a; CDC, 1981b; 
Deinstag et al., 1983; Dzik & Alter, 1982; Lee, Ip & 
Wong, 1978). HBV has been shown to be transmitted by 
sexual contact, perinatal exposure and perhaps by in-
sects (Beasley, Hwang & Cladd, 1983a; Chaudhary, 1983: 
Chin, 1983; Koff, Slavin & Connelly, 1977; Newkirk, 
Downe & Simon, 1975). 
Perinatal transmission appears to be the most 
important means of spreading HBV worldwide. In endemic 
areas, 80-90% of HBV infections appear to be spread by 
maternal to fetal transmission at the time of labor and 
delivery (Dzik & Alter, 1982; Okada, Kamiyama & Ino-
mata, 1976). Studies in Taiwan show that there is a 
40% rate of chronic carriers being perinatally infected 
(Beasley, 1982; Beasley et al., 1983). In view of 
this, asymptomatic hepatitis B carrier mothers serve as 
th~ primary reservoir for the HBV (Beasley, Lee & 
Hwang, 1983; Tada, 1982). Of those HBV carriers who 
are HBsAg(+), approximately 30-44% are also HBeAg(+) 
(Dzik & Alter, 1982; Stevens, 1982). 
Since HBeAg is usually found in association with 
the whole virus, a neonate whose mother is an HBV 
carrier HBeAg(+) has an 80-100% chance of contracting 
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the disease (Beasley & Trepo, 1977; Deinstag et al., 
1983; Lutwick, 1984; Okada et al., 1976). Once infect-
ed the newborn has an 80-90% risk of becoming a chronic 
HBsAg carrier as opposed to 6-10% risk if infected as 
an adult (Beasley, 1982; CDC, 1982; Stevens, 1982). 
Considering these statistics and the 12-14% HBV carrier 
rate in American Southeast Asian refugees, approximate-
ly 4 out of every 100 of their newborns are at risk of 
becoming chronic carriers. In addition, there appears 
to be an inverse relationship between the age HBV 
infection is acquired and the development of liver 
cirrhosis and primary hepatocellular carcinoma (Beas-
ley, 1982; CDC, 1982). Thus, the individual who 
acquires HBV infection through maternal transmission 
has a greater chance of developing cirrhosis and liver 
cancer than an individual who acquires HBV infection as 
an adult. In an elaborate study of 22,707 Taiwanese 
men, Beasley et ale (1981) revealed that those with 
HBsAg had an incidence of primary hepatocellular carci-
noma 233 times higher than noncarriers. 
The literature shows that perinatal transmission 
most likely occurs at or near the time of birth rather 
than in utero or during the postnatal period (Beasley 
et al., 1983b; Dzik & Alter, 1982; Goudeau, 1983; Wong, 
Lee & Henrietta, 1980). This is evident from the 
following factors. First, for some infants who become 
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HBsAg positive, cord blood is HBsAg negative at birth 
(Beasley et al., 1983a). Beasley et ale (1983b) also 
demonstrated that 58 out of 61 infants of carrier 
mothers (95.1%) who did not receive hepatitis B immune 
globulin (HBIG) at birth were HBsAg(+) at 3 months of 
age (Beasley et al., 1983a; Beasley et al., 1983b). 
The clinical incubation period of HBV ranges from 
60 to 180 days with an approximate mean of 100 days 
(Krugman, Overby & Mushahawar, 1979). Infants remain-
ing HBsAg(+) at 3 months after receiving HBIG at birth 
were most likely infected in utero (Beasley et al., 
1983a; Tada, 1982). Approximately 5-10% of infants are 
infected prior to birth (Beasley et al., 1983ai Chin, 
1983: Tada, 1982; Wong et al., 1980). This is probably 
due to maternal fetal transfusions as a result of 
bleeds or "leaks" across the placenta (Beasley & Trep-
po, 1977; Beasley et al., 1983; Beasley, Stevens, Shiao 
& Meng, 1975). 
During the perinatal period, there are several 
modes of hepatitis transmission. HBsAg has been iso-
lated in maternal vaginal secretions, amniotic fluid, 
saliva, breast milk and blood (Dienstag et al., 1983: 
Lee et al., 1978: Wong et al., 1980). In the newborn, 
HBsAg has been found in cord blood, peripheral blood, 
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and in gastric and nasal fluids (CDC, 1981a; Lee et 
al., 1978). Other portals of entry into the newborn 
blood stream besides maternal fetal transfusion and 
utero-placental leaks, include lesions resulting from 
scalp electrodes, fetal pH sampling and through abra-
sions caused by vigorous intubation and forceps (Chaud-
hary, 1983; Dienstag et al., 1983; Wong et al., 1980). 
Health care providers are also at risk when caring 
for the HBsAg individual during the perinatal period 
(CDC, 1981a; Werner & Grady, 1982). Precautions must 
be taken to prevent contamination with blood and body 
fluids. The risk of the health care provider becoming 
infected and developing a carrier state is small (Dzik 
& Alter, 1982), but due to the implications of the 
carrier state to the professional, care must be advised 
(CDC, 1982; Denes & Smith, 1978). 
Epidemiology 
The prevalence of hepatitis B varies from country 
to country and is conditional on a variety of social, 
environmental, behavioral and host factors. It has 
been estimated that there are at least 176,000,000 
chronic carr iers of HBsAg wor ldw ide (Sobes lavsky, 
1978). In northern, central and western Europe, North 
America and Australia (populations of British ancestry) 
HBsAg is detected in 1% or fewer members of the popula-
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tion, whereas the rates in southern and eastern Europe, 
the USSR, Central and South America, Africa, Asia, 
Oceania, South and West Pacific range from 2% to great-
er than 10% (Sobeslavsky, 1978: Szmuness, 1975: 
Szmuness, Harley & Ikram, 1978). 
The Asian continent has been found to have a high 
prevalence of HBV and in some areas may be as high as 
40% (Sobeslavsky, 1978: WHO, 1977). Refugees from 
Southeast Asia residing in the United States have been 
found to have a prevalence rate of HBsAg of 12-14% 
(Barry et al., 1983; CDC, 1981ai Lutwick, 1984). 
The prevalence of HBsAg has also been studied in 
relation to age. In a highly endemic area, such as 
Asia, the highest rates occur in the pediatric popula-
tion, often in the 0 to 4 year old age group (Sobeslav-
sky, 1978). 
transmission. 
This is a direct result of perinatal 
Other variables, many of which are interconnected, 
include lower socioeconomic status, lower level of 
education, history of parenteral drug abuse, dialysis, 
institutionalization (especially those with Down's 
syndrome), health care providers, and male homosexuals 
(Szmuness et al., 1978). There is an increased risk of 
the carrier state that occurs in hemodialysis patients, 
institutionalized Down's patients, and in infants born 
of chronic carrier mothers (Szmuness et al., 1978). 
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Reports that the Southeast Asian refugees have a 
high HBsAg carrier rate have raised many questions in 
the medical community. Many of the questions concern 
the issues of serologic testing and the care of preg-
nant women and neonates. The development of effective 
vaccines makes it important to recognize antepartum 
carriers of HBV, so that during the intrapartum period 
the infants can be identified and given prophylaxis so 
as not to become chronic carriers. It is also neces-
sary for health care providers to be aware of the HBV 
carriers, so they can take appropriate precautions to 
prevent transmission. 
The purpose of the present research was to deter-
mine the prevalence of hepatitis B virus among child-
bearing Southeast Asian women in the Salt Lake area. 
CHAPTER II 
METHODOLOGY 
A retrospective archival method was utilized in 
reviewing prenatal medical records from two Salt Lake 
County prenatal clinics for the following reasons: 
1. Given time limitations, it provided for a 
relatively large population from which to investigate 
the prevalence of hepatitis B among the Southeast Asian 
childbearing population. 
2. Both clinics are known in the community for 
service to and interest in the Southeast Asian popula-
tion. 
3. The accuracy of prenatal charting, documenta-
tion, and requisition of hepatitis B blood tests could 
be assessed. 
For the purpose of this study: 
1. Southeast Asian refugees were defined as those 
who immigrated to the United States from Vietnam, Thai-
land, Laos and Cambodia. 
2. The sample was limited to Southeast Asian 
women who delivered in 1984, and those who delivered in 
1985, or had prenatal blood tests drawn prior to 
February 28, 1985. 
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3. All Southeast Asian women who received pre-
natal care within the above time period were included 
in the study. 
4. Hepatitis B surface antigen was the serologic 
marker used to identify those subjects who were in the 
acute phase or were carriers of hepatitis B virus. 
5. Hospital medical records were reviewed for 
HBsAg positive subjects when available for pregnancy 
outcomes and management. 
Permission was obtained from appropriate authori-
ties at each clinic and hospital to acquire chart data 
pertaining to study of hepatitis B virus in childbear-
ing Southeast Asians. A code sheet was developed to 
record all pertinent data (see Appendix). All informa-
tion was coded to protect the anonymity of the 
individuals. Subjects were identified by coded numbers 
and medical record numbers and were not identified by 
name. 
CHAPTER III 
RESULTS AND DISCUSSION 
The investigation was conducted to obtain data 
concerning the prevalence of hepatitis B virus among 
Southeast Asian prenatal clients. The sample consisted 
of 129 charts retrospectively reviewed from two Salt 
Lake City prenatal clinics. The time period included 
all the Southeast Asian women receiving prenatal care 
who delivered in 1984 and 1985, and also included those 
who had not delivered but who had prenatal blood work 
prior to February 28, 1985. 
The data were analyzed using the Statistical 
Package for the Social Sciences (SPSS) for frequencies, 
general descriptive statistics, and the Fisher's Exact 
Probability Test. These statistics were calculated by 
the Univac 1100 computer at the University of Utah 
Computer Center. Percentages and differences between 
percentages were computed by hand calculator. Confi-
dence levels were established at the .05 level. 
Demographic Data 
The demographic data available in the charts con-
sisted of age, marital status, gravida, parity, and 
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ethnicity. Table 1 represents a demographic profile of 
the subjects. Ages ranged from 15 years to 44 years, 
with a mean age of 26 years (S.D.=6.6). Ninety-six 
percent of this population are married with the remain-
ing 4% single. The number of pregnancies per woman 
ranged from 1 to 10, with a mean of 3.5 (S.D.=2.3). It 
is of interest that the majority was Cambodian (60%). 
In most studies on the health status of Southeast Asian 
refugees, Vietnamese clients make up the largest group 
(Catanzaro & Moser, 1982; Barry et al., 1983). 
Screening for HBsAg 
Table 2 summarizes the number of subjects tested 
and not tested for HBsAg at the two clinic sites. Of 
the 129 charts reviewed, 75 (58%) were screened for 
HBsAg. There was no significant difference by clinic, 
in the percentage of subjects tested. 
Of the 75 subjects screened for HBsAg, 7 were 
HBsAg positive. The prevalence of HBsAg among South-
east Asians in the sample who were screened was 9.3% 
(see Table 3). As stated previously, Southeast Asian 
refugees residing in the United States have been found 
to have HBsAg prevalence rates of 12-14% (Barry et al., 
1983; CDC 1981ai Lutwick, 1984). The prevalence of 
HBsAg in this sample was somewhat below that reported 
in the literature. Due to the small sample size, the 
TABLE 1 
Demographic Profile of Sample Population 
Vietnamese Laotian Cambodian Hmong 
* (%): 11 (09%) 30 (24%) 75 (60%) 9 (7%) 
Age: 
15-20 0 (0% ) 8 (27 %) 75 (60%) 9 (7 %) 
21-30 8 (73%) 18 (60%) 45 (60%) 4 (44%) 
31-40 3 (27%) 3 (10%) 13 (17%) 0 (0% ) 
> 40 0 (0%) 1 (3%) 6 (8%) 0 (0%) 
Marital 
Status: 
M. 11 (100%) 29 (97%) 71 (95%) 9 (100%) 
S. 0 (0%) 1 (3%) 4 (5%) 0 (0%) 
Gravida 
(mean) : 3 .8 (s. d. =2.4 ) 2.6 (s.d.=1.5) 3.8 (s.d.=2.5) 3.7 (s.d.=2.9) 
Clinic 
Site: 
fl 2 (18%) 14 (47%) 5 (07 % ) 1 (11%) 
#2 9 (82%) 16 (53%) 70 (93%) 8 (89%) 
This table represents 97% of the sample population. 








Comparison of Testing for HBsAg 
in Two Clinic Sites 









hepatitis B surface antigen 
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Comparison of HBsAg Positive Results and 
HBsAg Negative Results 
at each Clinic Site 
Site HBsAg HBsAg Total # 
Positive ( % ) Negative ( % ) of Subjects ( % ) 
Clinic 1 1 ( 7 ) 13 (93) 14 (19) 
Clinic 2 6 (10) 55 (90) 61 (81) 
TOTALS 7 ( 9 .3) 68 (90.7) 75 (100) 
HBsAg hepatitis B surface antigen 
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researcher cannot be confident of the external 
validity. 
By rough inspection, it appeared that the Cambod-
ian population had a higher prevalence for positive 
HBsAg than the other nationalities tested (see Table 
4). Using the Fisher's Exact Probability Test, no 
significant difference between nationality and 
prevalence could be determined. 
Comparison of HBsAg Positive Subjects 
Of the 7 positive HBsAg subjects identified, 2 
have not delivered yet, I transferred out of the area 
prior to delivery, and 4 delivered at a major Salt Lake 
area hospital. 
Four out of the seven charts had instructions to 
alert pediatricians at the delivery to provide prophy-
laxis for the newborns. There was no consensus of how 
to manage the HBsAg positive pregnant women (see Table 
5). Four subjects received no followup blood tests 
after being found HBsAg positive in the prenatal 
period. Two were tested for HBs antibodies and found 
to be negative. One was tested for HBeAg, and one 
subject had liver function tests. 
Infants of HBsAg Positive Mothers 
Infants born to HBsAg positive mothers were sub-








Comparison of Negative and Positive 
HBsAg Tests by Nationality 
HBsAg HBsAg 
Negative(%) positive ( % ) 
4 (8 ) 1 ( 2 ) 
14 (93) 1 (7 ) 
45 (90) 5 (10) 
3 (100) 0 ( 0 ) 
2 (100) 0 (0 ) 







3 ( 4 • 0 ) 

















HBeAg Anti-HBc Tests That Were Done 
NT NT None 
NT NT Anti-HBs, LFT 







NT Scheduled for HBeAg and 
Repeat HBsAg at term 
NT None 
hepatitis B surface antibody 
hepatitis B He" antigen 
hepatitis B core antibody 
liver function tests 
not tested 
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infants were not given prophylaxis for hepatitis and 
two received the hepatitis B immunoglobulins (HBIG) in 
addition to the hepatitis B vaccine. The hepatitis B 
vaccine, when used in conjunction with the hepatitis B 
immunoglobulin (HBIG), has been found to be 94% effec-
tive in preventing the carrier state in the newborn 
(Beasley et al. 1983a). 
The two infants who received prophylaxis were also 
scheduled for further vaccinations. One infant was 
scheduled at 1 and 6 months intervals, and the other 
was scheduled at 2 and 4 month intervals. The Center 
for Disease control Immunization Practices Advisory 
Committee recommends that the HBIG and hepatitis B 
vaccine be given at delivery and hepatitis B boosters 
given at 1 and 6 month intervals (CDC, 1984). 
All infants were monitored during labor with 
internal fetal scalp electrodes. The electrodes are 
attached with a small wire to the infant's head while 
in the birth canal. Fetal scalp electrodes cause a 
break in the skin, thus further exposing the infant to 
the hepatitis B virus. The use of forceps for delivery 








Type of Delivery, Interventions and Vaccinations 
of Infants of HBsAg Positive Subjects 
Type of Use of FSE HbIg 
Delivery or Scalp pH Given 
NSVD FSE NO 
NSVD FSE YES 
FORCEP SCALP pH YES 
FSE 
NSVD SCALP pH NO 
Normal Spontaneous Vaginal Delivery 











2 and 4 months 





SUMMARY AND RECOMMENDATIONS 
Summary 
The aim of this study was to determine the preva-
lence of hepatitis B in the Southeast Asian childbear-
ing population. 
The researcher utilized the medical records of 129 
Southeast Asian women who received prenatal care at two 
Salt Lake area clinics. Hospital medical records were 
also reviewed for four select cases. The subjects 
delivered in 1984/1985 and those undelivered had pre-
natal blood work prior to February 28, 1985. Computer 
analysis of the data included frequencies, descriptive 
statistics, and Fisher's Exact Probability Test. 
The literature review revealed that prenatal 
transmission of the hepatitis B virus is a major means 
of spreading the infection. The general U.S. popula-
tion carrier rate of 0.1 to 0.5% is quite low compared 
to the 12-14% carrier rate among the Southeast Asian 
population. Of vital importance is that hepatitis B 
may lead to fatal hepatitis in the newborn and cirrho-
sis of the liver and primary hepatocellular carcinoma 
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in the adult. Health care providers are also at great 
risk when caring for a hepatitis B infected individual. 
The results of this study produced demographic 
data for the prenatal Southeast Asian population in two 
clinics in the Salt Lake area. The sample consisted of 
60% Cambodian, 24% Laotian, 9% Vietnamese, and 7% 
Hmong. There were no major differences noted between 
the subgroups. Because it was believed that all South-
east Asians were being screened for hepatitis B, the 
original purpose of this study was to determine the 
prevalence of the disease. Out of 129 subjects, 75 
(58%) were screened for HBsAg. Of the 75 Southeast 
Asians screened, 7 (9.3%) were HBsAg positive. This 
result was below the 12-14% rate cited in the litera-
ture. Undoubtedly, the size of the sample limits the 
generalizability of the findings to other samples, and 
caution must be used in interpreting the results. A 
major limitation of this research was the use of a 
retrospective design that did not allow for complete 
record keeping. The use of records that have not been 
kept for specific research needs are often incomplete 
and in some cases inaccurate. 
In reviewing the prenatal charts and hospital 
records, a lack of consistency was seen in the manage-
ment of HBsAg positive pregnant women and their 
infants. 
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Recommendations for Practice 
Due to the large number of resettled Southeast 
Asians in the Salt Lake area, most obstetrical care 
providers will at one time be faced with the perplexity 
of prenatal hepatitis B. The first step for prevention 
is to identify the pregnant woman who is a potential 
HBV carrier. The Center for Disease Control recommends 
that women with the following risk factors should have 
serologic screening prenatally (CDC 1981a): 
1. Asian descent or birth in an endemic area. 
2. Acute or chronic liver disease. 
3. Rejection as a blood donor. 
4. Work or treatment in a dialysis unit. 
S. Working or living in an institution with 
Down's patients. 
6. Percutaneous drug abuse. 
7. Household members with hepatitis B. 
8. Prostitution. 
9. Occupational exposure to blood. 
A mother may be HBsAg positive due to an acute 
hepatitis B infection during pregnancy, or because she 
is a chronic carrier. The chronic carrier state is 
defined as being HBsAg positive at two times, at least 
6 months apart (CDC, 1981b). It is important to test 
the HBsAg positive mother for HBeAg to determine the 
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stage and infectivity of the illness. This does not, 
however, alter the care of the newborn, since all HBsAg 
positive individuals are at risk of transmitting hepa-
titis B. 
It is also recommended that in clinics where care 
is provided by many different staff members, the hepa-
titis screen be a routine part of the initial prenatal 
blood work. This may help to reduce the number of 
patients which are not being screened. 
In the cases where the hepatitis screen is posi-
tive, care must be taken to minimize exposure of the 
infant to contaminated maternal body fluids. Judicious 
use of fetal scalp electrodes and operative deliveries 
is advised. Protocols for use of hepatitis B immuno-
globulin and hepatitis B virus vaccine for newborns 
must be standardized and made available at deli very. 
The use of the public health system for follow up on 
the newborns may help with compliance. 
Exposure to hepatitis B constitutes a serious 
occupational hazard to many health care workers. The 
provider who receives a puncture from a needle contami-
nated with blood containing hepatitus B virus has a 20% 
chance of becoming infected (CDC, 1981b). Health care 
providers must be made aware of the effect of hepatitis 
B. In clinics with a high risk population, the 
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hepatitis B vaccine should be made available to the 
health care providers. 
Recommendations for Further Study 
Based on the information derived from the findings 
the researcher offers several recommendations for 
further research of this nature. 
1. The study should be repeated using a larger 
sample size with subjects from a greater variety of 
clinic sites. 
2. Comparison research should be conducted at a 
later date to determine if a greater percentage of 
women are being screened for HBsAg. 
3. It is necessary to learn if staff members are 
aware of the implications of HBsAg positive mothers and 
infants. Inservice education about hepatitis B might 
increase the screening rate of high risk clients. 
APPENDIX: CODE SHEETS 
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Hepatiti. B Code Sheet 
Variable Humber of Column 
Number Item Code(s) Columns Numbers 
0 I.D. # 3 1-3 
---
1 Clinic 1 - RWMC 2 1+-5 
2 - SLCC 
3 - OTHER 
2 Age 2 6-7 
3 Gravida 2 8-9 




5 Mari tal 1 • Married 2 14-15 
2 • Single 
3 - Divorced 
4 
- Other 
6 Nationality 1 - Vietnamese 2 16-17 
2 - Laotian 
3 - Cambodian 
4 
- Hmong 
5 - Other 
7 Prevo Delivery Year 2 18-19 (date ) 
8 Month 2 20-21 
9 Date 2 22-23 
10 Cont. Use 1 • Yes 2 24-25 
2 • No 
11 Type Cont. 1 - BC Pills 2 26-27 
2 
- Barrier 
3 • IUD 
1+ • Other 
12 Place Prevo Delivery 1 • SLC 2 28-29 
2 • Other U.S. Area 
3 • Home Country 
1+ - Other 
13 Tested for HBsAg 1 • Not ~e.~ed 2 30-31 
2 - Te.~ed 
14 HBsAg 1 - Positive 2 32-33 
2 • Negative 
3 - Not Tested 
8 • Not available 
9 - Hilling data 
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Positive HBsAg Code Sheet 
Variable Number of Column 
Number Item Code(s) Columns Numbers 
15 HBeAg 1 - Positive 2 34-35 
2 - Negative 
3 - Not Tested 
16 Anti-HBc 1 - Positive 2 36-37 
2 - Negative 
3 - Not tested 
17 EDC (date) Year 2 38-39 
18 Month 2 40-41 
19 Date 2 42-43 
20 Date of Del. Year 2 44-45 
21 Month 2 46-47 
22 Date 2 48-49 
23 Type of Del. 1 - NSVD precip. 
2 - NSVD Controlled 
2 50-51 
3 - Forcep/Vacuum 
4 
- CIS 
24 Place of Del. 1 - Holy Ct'08S 2 52-53 
2 - Univ. of Utah 
3 - Other SLC HOlpital 
4 
- Othet' 
25 HBiG 1 
- Yes 2 54-55 (to newbot'n) 2 • No 
26 Followup 1 - Yel 2 56-57 
1-6 months Icheduled 2 
- No 
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